GO
Loading...

Pfizer Inc

More

  • Chantix Ad

    While thumbing through “Parade” magazine yesterday, the fluffy publication that you find tucked inside some Sunday newspapers, I noticed an ad for Pfizer’s stop-smoking drug Chantix. It caught my eye because the company had stopped doing what’s called “branded” advertising for the pill earlier this year because of new safety concerns...

  • Fixing Pfizer And Your Emails Friday, 2 May 2008 | 2:02 PM ET

    It's the kind of artwork I'm sure they weren't happy to see at Pfizer spacer headquarters this morning. The torn company logo on the front page of the Newark Star-Ledger business section above the headline, "Signs of Wear and Tear."

  • Ford Stock Fan Offers More Picks Thursday, 1 May 2008 | 12:31 PM ET

    On St. Patrick's Day (March 17), Bernie McGinn saw a lot of green for Ford: he told CNBC the automaker was a "buy." Since then, the troubled carmaker's shares are up 65.2 percent.  Where's the head of McGinn Investment Management going now?

  • Forget Fed Watch Monday, 28 Apr 2008 | 6:15 PM ET

    Wall Street’s on the edge of its seat ahead of Wednesday’s interest-rate announcement. You should be on the phone with your broker.

  • The Week:  Trading By the Numbers Saturday, 26 Apr 2008 | 11:42 AM ET

    Earnings Season shifted into high gear, both corporate results and economic statistics were all over the proverbial map, and investors and traders found opportunities in some unlikely places.

  • Amgen: Is "A" For Anemia Or Acquisition? Friday, 25 Apr 2008 | 12:35 PM ET
    AMGEN

    The morning after Amgen reported its first quarter earnings my inbox runneth over with analyst research reports on the biotech behemoth. The company beat the Street by eight cents a share. But the focus remains on the anemia drug franchise.

  • Pfizer's Kindler Doesn't Duck Tough Questions Thursday, 24 Apr 2008 | 1:55 PM ET
    Jeff Kindler, Pfizer Chairman and CEO

    Pfizer held its shareholder meeting Thursday morning at the historic Memphis hotel where the ducks march through the lobby. I haven't seen the spectacle yet, but I'm told it's quite the scene. Watch my exclusive interview with Chairman and CEO Jeff Kindler.

  • Schering Plows Through Vytorin Firestorm Wednesday, 23 Apr 2008 | 12:57 PM ET

    Schering-Plough beat the Street by a surprising 16 cents per share and the beaten-down shares are rallying. In an exclusive CNBC interview Wednesday morning, Chairman and CEO Fred Hassan explained how the company was able to blow away estimates...

  • Halftime Report: Da Bears Are Winning Tuesday, 22 Apr 2008 | 12:41 PM ET

    This halftime report is not brought to you by (pick your prescription drug). So, we're pretty much at the midway point of big pharma's earnings season and Goldman Sachs analyst James Kelly is sizing things up so far...

  • Pfizer Falls Below $20 Tuesday, 22 Apr 2008 | 12:29 PM ET

    Pfizer's slide continues.  The stock has now fallen below $20 for the first time since 1997. 

  • Soaring Oil a Drag on Markets Tuesday, 22 Apr 2008 | 12:21 PM ET

    Stocks dropped mid-morning as oil is spiking just shy of $120. At this point, oil is a major drag on the markets. Speaking of stocks: we are about one-third through with first-quarter earnings, and it is not shaping up to be a great start.

  • Playing the Pharma Numbers Monday, 21 Apr 2008 | 10:46 AM ET

    Merck's revenues were light, but market reaction was positive.  Eli Lilly's earnings were up sharply, but still disappointed the Street.  So how does an investor play the results?

  • Bank Of America Continues Monday Woes Monday, 21 Apr 2008 | 9:37 AM ET

    Monday has not been a great day for bank earnings. Last Monday it was Wachovia that disappointed, today futures dropped at 7 am ET as Bank of America came short of expectations.

  • Week Ahead: The Big Test Friday, 18 Apr 2008 | 8:09 PM ET

    Whenever the stock market rushes full speed ahead, it is hard not to look for the big let-down. That could be the case in the week ahead... Major earnings reports, housing data, annual shareholder meetings, and Tuesday's Pennsylvania presidential primaries are what traders will be watching to see if the trend continues.

  • Bitter Pill? Friday, 18 Apr 2008 | 6:28 PM ET

    Was Pfizer's miss, a prescription for disaster in Big Pharma? Should you sell drug makers ahead of earnings next week?

  • Springtime for Pharma: A Big Week Ahead For Earnings Friday, 18 Apr 2008 | 12:01 PM ET

    The irreverent producers of "Squawk on the Street" who are stationed in the pod next to mine here at CNBC like to call it "Pharmapalooza." They're referring to weeks like the one coming up when nearly every big drug company reports earnings.

  • Stocks Flat But Earnings News Abound Thursday, 17 Apr 2008 | 7:09 PM ET

    Google hits it out of the park, Merrill posts a loss but shares climb anyway and Pfizer plummets. All the earnings trades and much more right here.

  • The Case For Being Bullish Thursday, 17 Apr 2008 | 4:37 PM ET

    Futures popped right after the close as Google reported strong numbers; up 10 percent. Major indices stable today, despite mixed earnings report. IBM, good, Marriott, ok on strong international sales, but Conway, Nokia and Pfizer were notable disappointments.

  • Stocks Finish Flat; Financials Rebound Thursday, 17 Apr 2008 | 4:26 PM ET

    Stocks wobbled Thursday as investors digested a mixed bag of earnings and economic news. IBM was the biggest gainer on the Dow, while Pfizer was the biggest decliner.

  • Pfizer, UTX Drag on Dow; Merrill Rises Thursday, 17 Apr 2008 | 3:18 PM ET

    Stocks wobbled Thursday as investors digested a mixed bag of earnings and economic news. IBM was the biggest gainer on the Dow, while Pfizer was the biggest decliner.